Bytom

Poland

50 total trials 19 recruiting

Filter these 50 trials by phase, condition, sponsor and more.

Open in Search →

Phase 3b/4 Study in Rheumatoid Arthritis Ended

2023-508022-10-00 6 2019-07-25 Rheumatoid Arthritis
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3 … Ended

2022-501251-81-00 5 2017-06-08 Renal cell carcinoma

Showing 49–50 of 50 trials